title: [Psychopharmacotherapy of psychotic disorder during pregnancy and lactation].
abstract: The aim of our work based on the global literature-review is to present the guidelines of the psychopharmacotherapy during pregnancy and lactation recommended by various experts-groups as followed: 1. American Academy of Pediatrics, American Psychiatric Association, American College of Obstetricians and Gynecologists, The Maudsley Guidelines, Department of Psychiatry, Medical University of Mainz, Institute of Psychiatry and Neurology in Warsaw. In the first part the guidelines concerning to psychopharmacotherapy of psychotic disorders have been presented and actual data about spreading of these illnesses, pre- and perinatal effects of drugs used, the classification of neuroleptic drugs according to FDA and the safety of these medicines for the breast fed newborn.
authors.affiliation: Klinika Psychiatrii AM w Lublinie.
authors.forename: Hanna
authors.initials: H
authors.lastname: Karakuła
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Szajer
authors.forename: Justyna
authors.initials: J
authors.lastname: Pawezka
authors.forename: Anna
authors.initials: A
authors.lastname: Grzywa
authors.forename: Adam
authors.initials: A
authors.lastname: Gut
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Przywara
mesh_terms: D001942:Breast Feeding; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D006801:Humans; D007229:Infant Welfare; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D008429:Maternal Welfare; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D011619:Psychotropic Drugs